T45.692 Poisoning by other fibrinolysis-affecting drugs, intentional self-harm

Name of the Condition

• Poisoning by other fibrinolysis-affecting drugs, intentional self-harm (ICD-10 code: T45.692)

Summary

This condition involves intentional self-harm resulting from exposure to fibrinolysis-affecting drugs not classified elsewhere. It includes harmful effects due to excessive dosing, deliberate ingestion, or self-administration of these medications, which modulate the body's ability to dissolve blood clots. The term "other" specifies drugs outside the thrombolytic class, such as certain plasminogen activators or fibrinolytic agents.

Causes

Intentional self-harm may occur from deliberate ingestion or self-administration of fibrinolysis-affecting drugs. This can result from suicidal intent, medication misuse, or intentional overdose. Underlying factors like altered drug metabolism or patient-specific sensitivities may exacerbate adverse effects.

Risk Factors

• High doses or prolonged use of fibrinolysis-affecting drugs.
• Concurrent use of anticoagulants or antiplatelet agents.
• Pre-existing liver or kidney impairment affecting drug clearance.
• Age-related changes in drug sensitivity (e.g., elderly or pediatric patients).
• History of bleeding disorders or prior adverse drug events.
• Mental health conditions or suicidal ideation.

Symptoms

• Excessive bleeding (e.g., bruising, hematomas, gastrointestinal bleeding).
• Uncontrolled clot breakdown leading to hemorrhage.
• Hypotension or shock due to blood loss.
• Neurological symptoms (e.g., dizziness, confusion, or loss of consciousness).
• Respiratory distress or organ dysfunction from systemic effects.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and toxicology screening. Laboratory tests may assess coagulation parameters (e.g., PT, aPTT, fibrinogen levels) and drug levels. Imaging or endoscopic procedures may be used to identify bleeding sites. Documentation of intentional self-harm is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, controlling bleeding, and managing complications. Interventions may include administering antidotes (if available), blood product transfusions, or hemostatic agents. Supportive care, such as fluid resuscitation or mechanical ventilation, may be necessary. Psychiatric evaluation and intervention are essential for addressing underlying intent.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, promptness of treatment, and underlying health status. Early intervention improves outcomes, but severe bleeding or organ damage may lead to long-term complications. Follow-up includes monitoring for recurrent bleeding, assessing mental health, and adjusting medications as needed.

Complications

• Severe or life-threatening hemorrhage.
• Organ failure (e.g., renal, hepatic, or cardiovascular).
• Neurological deficits from hypoxia or blood loss.
• Psychological sequelae related to self-harm.
• Long-term disability from irreversible tissue damage.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Education on proper medication use and disposal.
• Mental health support and crisis intervention.
• Regular monitoring of high-risk patients.
• Avoidance of drug interactions through provider communication.

When to Seek Professional Help

Seek immediate medical attention if experiencing uncontrolled bleeding, dizziness, confusion, or signs of shock. Prompt care is critical to prevent severe complications. Mental health professionals should be consulted for ongoing support.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes T45.692 from other poisoning codes. Include details about the specific fibrinolysis-affecting drug, dosage, and clinical manifestations. Ensure alignment with ICD-10-CM guidelines for poisoning and self-harm coding.